Covenant Asset Management, LLC Incyte Corp Transaction History

Covenant Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 22, 2020	SELL	$63.18 - $85.97 $1.15 Million - $1.56 Million	-18,140 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$73.04 - $95.72 $130,084 - $170,477	1,781 Added 10.89%	18,140 $1.58 Million
Q3 2019 Oct 18, 2019	BUY	$72.82 - $86.52 $62,770 - $74,580	862 Added 5.56%	16,359 $1.21 Million
Q2 2019 Jul 17, 2019	BUY	$73.52 - $88.7 $351,940 - $424,606	4,787 Added 44.7%	15,497 $1.32 Million
Q1 2019 Apr 26, 2019	BUY	$63.56 - $88.17 $680,727 - $944,300	10,710 New	10,710 $921,000
Q1 2018 May 04, 2018	SELL	$83.06 - $100.98 $1.32 Million - $1.6 Million	-15,840 Closed	0 $0
Q4 2017 Jan 12, 2018	SELL	$93.56 - $116.6 $7,859 - $9,794	-84 Reduced 0.53%	15,840 $1.5 Million
Q3 2017 Oct 19, 2017	BUY	$109.15 - $138.27 $1.74 Million - $2.2 Million	15,924	15,924 $1.86 Million

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Covenant Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Covenant Asset Management, LLC with notifications on news.